Accessibility statement

Clinical Trials Sponsorship Committee

Terms of Reference

Terms of Reference

The Terms of Reference are currently being revised.

  1. Take overall responsibility for policy and procedure relating to clinical trials, including development of such policies and procedures as appropriate
  2. Take overall responsibility for ensuring that the University fulfils its legal duties as Sponsor or Co-Sponsor, including the decision to Sponsor, Co-Sponsor or participate in a CTIMPs trial
  3. Be kept informed of non-MHRA regulated trials approved by RE

Information on this website should be read in conjunction with the University Policy for Clinical Research.

Reports to

University Research Committee

Frequency of meetings

The Committee shall meet on a twice-yearly basis and conduct urgent business electronically, or by arrangement of additional meetings, in the interim.


Definitions taken from glossary of the Medical Research Council Experimental Medicine Toolkit.


An individual, company, institution or organisation which takes responsibility for the initiation, management and/or financing of a clinical trial (from the EU Directive 2001/20/EC).

Clinical Trial

A clinical trial is any prospective evaluation of a healthcare intervention, which involves the administration of a treatment or type of management, including diagnosis or the provision of lifestyle (eg dietary) advice.


Clinical Trial of an Investigational Medicinal Product, ie a clinical trial that is within the scope of the UK Medicines for Human Use (Clinical Trials) Regulations 2004.


An Investigational Medicinal Product is a pharmaceutical form of an active substance or placebo being tested or used as a reference in a CTIMP. This includes products already with a marketing authorisation: when used or assembled (formulated or packaged) in a way different from the authorised form, when used for an unauthorised indication, or when used to gain further information about the authorised form.

Issue date: September 2010, updated September 2021


Committee Membership

1 Chair
2 Dean of the Hull York Medical School (HYMS), or their representative
3 The Director of the York Clinical Trials Unit
4 The Director of the Research and Enterprise Office
5 The Contracts and Sponsorship Manager
6 Representative of the Research and Development office of the York Teaching Hospitals NHS Foundation Trust
7-12 Members of University of York or NEY NHS Alliance staff who are engaged in, or who have experience of, clinical trials


1 Professor Karl Atkin Chair
2 Vacant HYMS, Director of Research
3 Professor David Torgerson Health Sciences
4 Jennifer Gilmartin (Acting) Research and Enterprise
5 Dr Michael Barber Research and Enterprise
6 Dr Deborah Philips York Teaching Hospitals NHS Foundation Trust
7 Professor Charles Lacey HYMS
8 Professor Paul Kaye HYMS
9 Sarah Cockayne Health Sciences
10 Professor Eve Roman Health Sciences

For Members

Additional documents and information are available to members of the research committee.

Contact details

Claire Walsh
Research Policy Officer (Compliance)